If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
7
Followers on Owler
Neuraltus
researches, discovers, develops and commercializes therapeutics for the treatment of neurodegenerative diseases...
Read more
Overview
Competitors
Funding
News & Insights
Neuraltus
researches, discovers, develops and commercializes therapeutics for the treatment of neurodegenerative diseases...
Read more
President & CEO
Richard L. Casey
CEO Approval Rating
69/100
Weigh In
2004
Palo Alto
California
San Francisco Bay Area
Private
Pharmaceuticals & Biotechnology
Pharmaceuticals
Biotechnology
2834
2836
NAICS listing
http://www.neuraltus.com
Est. Annual Revenue
$5.0-25M
Agree?
Yes
No
Est. Employees
1-25
Agree?
Yes
No
Funding
$31M
News
Latest News
Aug 09, 2018
BioPortfolio
Neuraltus: Neuraltus Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250
Apr 26, 2018
PharmiWeb
Neuraltus: Neuraltus Pharmaceuticals Reports Results from Phase 2 NP001 Study in Amyotrophic Lateral Sclerosis (ALS)
Mar 25, 2018
BioPortfolio
Neuraltus: Neuraltus Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13032018 Prices from USD $250
Dec 26, 2017
BioPortfolio
Neuraltus: Neuraltus Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 28112017 Prices from USD $250
Sep 21, 2017
BioPortfolio
Neuraltus: Neuraltus Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 28082017 Prices from USD $250
Sep 13, 2017
BioSpace
Neuraltus: Neuraltus Pharmaceuticals, Inc. And The University of Hawaii At Manoa Announce Initiation Of Phase Ib Study Of NP001 In Patients With Mild-To-Moderate Alzheimer's Disease
Jul 12, 2017
BioSpace
Neuraltus: Neuraltus Pharmaceuticals, Inc. Announces Completion Of Enrollment In Confirmatory Phase II Study Of NP001 In ALS Patients With Systemic Inflammation
May 25, 2017
BioPortfolio
Neuraltus: Neuraltus Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 10052017 Prices from USD $250
Apr 03, 2017
BioSpace
Neuraltus: Neuraltus Pharmaceuticals, Inc. Release: Retrospective Analysis Finds Amyotrophic Lateral Sclerosis Patients With High Serum C-Reactive Protein (CRP) Levels May Respond To Immune Regulators Like NP001
Mar 31, 2017
BioPortfolio
Neuraltus: Neuraltus Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 17022017 Prices from USD $250
Follow and Get Alerts
Neuraltus Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 14 + competitors
Trending Companies